Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Jan;98(1):e13916.
doi: 10.1097/MD.0000000000013916.

Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node

Affiliations
Observational Study

Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node

Yidong Zhou et al. Medicine (Baltimore). 2019 Jan.

Abstract

To predict the factors related to axillary nonsentinel lymph node (NSLN) metastasis in patients with positive sentinel lymph node (SLN) of early breast cancer.The retrospective data are collected from the patients with positive SLN who received further completion axillary lymph node dissection (cALND) in Peking Union Medical Hospital between March 2016 and December 2017. Univariate analysis was conducted on data with various clinicopathologic factors at first. Those factors with statistic significance (P < .05) in univariate analysis were then used to implement multivariate analysis and logistic regression.There were total of 734 patients who received SLN biopsy , among whom 153 cases were included in our study. About 39.22% (60/153) of 153 paitents with positive SLN had no NSLN metastasisted to SLN. Univariate analysis showed that 3 variables were significantly correlated with NSLN involvement: tumor size (X = 10.384, P = .001), SLN metastasis ratio (number of positive SLNs/number of SLNs removed × 100%) (X = 10.365, P = .001) and the number of negative sentinel nodes (X = 10.384, P = .006). In multivariate analysis and logistic regression, tumor size (odds ratio [OR] = 3.392, 95% confidence interval [CI]: 1.409-8.166, P = .006) and SLN metastasis ratio (OR = 3.514, 95% CI: 1.416-8.72, P = .007) were the independent risk factors. While the number of negative sentinel nodes (OR = 0.211, 95% CI: 0.063-0.709, P = .014) was the independent protective factor. The calculated risk resulted in an area under the curve of 0.746 (95% CI: 0.644-0.848), suggesting stable discriminative capability in Chinese population.For those patients with positive SLN, larger tumor burden and SLN metastasis ratio are independent risk factors for NSLN metastasis. However, the more of the detected negative SLN, the less possibility with NSLN involvement.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Patient selection and collection of data for Peking Union Medical College Hospital patient series. About 203 patients with sentinel lymph node involment from the retrospective database in whom 156 meet the inclusion standard. At last 153 cases are eligible to be enrolled in the study.
Figure 2
Figure 2
Receiver operating characteristic curves for the patient series in Peking Union Medical College Hospital (PUMCH). When we evaluate the predictive value of the model for the patients from PUMCH, we obtain a bootstrap-corrected the area under the curve of 0.746.

Similar articles

Cited by

References

    1. Chalasani P, Downey L, Stopeck AT. Caring for the breast cancer survivor: a guide for primary care physicians. Am J Med 2010;123:489–95. - PubMed
    1. Ding B, Qian L, Zhao Y, et al. Meta-analysis of endoscopic axillary lymph node dissection versus conventional open excision for breast cancer [in Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2015;40:782–9. - PubMed
    1. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927–33. - PMC - PubMed
    1. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569–75. - PMC - PubMed
    1. National Comprehensive Cancer Network (NCCN). Clinical practices guidelines in oncology: breast cancer, version 2.2012. Available at: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf Accessed August 20, 2012.

Publication types

Substances